Advanced Cancer: Targeted Drug Study

We are investigating whether approved cancer drugs can help patients with advanced cancer who have specific genetic markers. This study aims to improve treatment options by using these drugs in new ways.

Efficacy phase (II)Post-Trial Drug Access No Placebo Investigational Medicines Oral InjectionOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Alecensa

Alecensa is a cancer medicine used to treat certain types of lung cancer caused by specific genetic changes.

Avastin

Avastin is a cancer medicine used to slow tumor growth by stopping tumors from getting new blood vessels.

Bortezomib Eg

Bortezomib Eg is a cancer medicine used to treat multiple myeloma and certain types of lymphoma.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Alectinib Hydrochloride

Alectinib hydrochloride is a substance that targets lung cancers with an ALK gene change to slow tumor growth and spread.

Alpelisib

Alpelisib is a substance that targets a cancer growth pathway to treat certain breast cancers with specific gene mutations.

Amivantamab

Amivantamab is a substance that targets specific proteins on certain lung cancer cells to help control advanced non-small-cell lung cancer with EGFR exon 20 mutations.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Tepmeko

Mekinist

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Abevmy

Abormib

Adabonib

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Helse Bergen HF

Oncology

Bergen, Norway

Nordlandssykehuset HF

Oncology

Bodø, Norway

Sykehuset Innlandet HF

Oncology

Brumunddal, Norway

Sponsor: Oslo University Hospital HF

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.